Default image

Bone Marrow Transplant Program

SLCH: Pediatric Stem Cell Transplant and Cellular Therapy Program

St. Louis Children’s Hospital has provided pediatric bone marrow transplants since 1991. Our bone marrow transplant program was the first of its kind in Missouri, created specifically for children. Now, our pediatric Stem Cell Transplant and Cellular Therapy Program offers three types of treatment: stem cell transplant, bone marrow transplant, and cellular therapy

Default image

Brain Tumor Program

SLCH: Pediatric Brain Tumor Program

When your child is diagnosed with a brain tumor, you want the best care imaginable. You want the most advanced treatments, experienced specialists and a team focused on your child’s long-term quality of life.

Default image

Cancer Predisposition Program

SLCH: Genetic Testing for Pediatric Cancer

Knowing your child may have an increased risk for cancer can be worrisome. Fortunately, we know genetic testing for cancer can improve the chance of finding and treating some cancers at an early stage.

Default image

Comprehensive Bleeding Disorder Program

SLCH: Bleeding Disorders Center

Children diagnosed with bleeding disorders can lead safe and full lives when they receive proper treatment and manage their conditions.

The Bleeding Disorders Center at St. Louis Children’s Hospital provides you and your child with the education, support and empowerment you need to help your child navigate treatment — and all of life’s possibilities — safely.

Default image

Global Neuro-Oncology Program (GNOP)

WUSM: Global Neuro-Oncology Program (GNOP)

The Global Neuro-Oncology Program (GNOP) was established to foster partnerships between Washington University and other institutions throughout the world aimed at addressing disparities in cancer care through research, education, outreach, capacity building and technological innovations.

Default image

Heartland Southwest Sickle Cell Disease Network

One of five HRSA-funded regions in the United States

Funded by a grant from Health Resources and Services Administration (HRSA) for the purpose of improving care and quality of life of people with sickle cell disease in the eight-state region.

Default image

Late Effects Program

SLCH: Childhood Cancer Survivorship Program

Chemotherapy, radiation and surgery are vital treatments for many pediatric cancer patients. But these lifesaving measures can take a toll on young bodies. Some side effects of childhood cancer treatment may not show up for many years. These side effects are called late effects.

Default image

Leukemia & Lymphoma Program

WUSM: Pediatric Leukemia & Lymphoma Program

Our program consists of eight core faculty members, as well as many highly-skilled fellows, residents, nurse practitioners, nurse coordinators and nurses. This page offers four sections to introduce you to the academic missions of the program, including patient care, research and teaching.

Default image

New Therapeutic Agents Program

SLCH: Investigational Agents and Phase 1

The Investigational Agents and Phase 1 Program offers several treatment regimens that provide the newest drugs and therapies available for children with malignant diseases. Both Phase I and Phase II clinical trials are available for patient enrollment.

Default image

Sickle Cell Program

SLCH: Sickle Cell Disease Program

Sickle cell disease often impacts all aspects of children’s lives, but it doesn’t have to control their lives. St. Louis Children’s Hospital has the largest and most experienced sickle cell program in Missouri. We help children and families manage this condition and obtain the best quality of life possible.